{"resourceType": "EvidenceVariable", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"], "versionId": "64", "lastUpdated": "2025-03-16T11:59:31.863Z"}, "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "urn:ietf:rfc:3986", "value": "https://fevir.net/FOI/236536", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-group-assignment-85390-85789", "assigner": {"display": "Computable Publishing LLC"}}], "title": "GroupAssignment: GLP-1 RA vs. Standard care", "status": "active", "author": [{"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}], "definition": {"concept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "defined-in-handling-and-category", "display": "Defined in handling and category elements"}]}}, "handling": "dichotomous", "category": [{"name": "GLP-1 RA", "valueReference": {"type": "Group", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-intervention-85390-I-85789", "assigner": {"display": "Computable Publishing LLC"}}, "display": "Glucagon-Like Peptide-1 (GLP-1) receptor agonists", "reference": "Group/236532"}}, {"name": "Standard care", "valueReference": {"type": "Group", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-comparator-85390-C-85789", "assigner": {"display": "Computable Publishing LLC"}}, "display": "Standard care", "reference": "Group/236530"}}], "url": "https://fevir.net/resources/EvidenceVariable/236536", "id": "236536", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "name": "GroupAssignment_GLP_1_RA_vs_Standard_care", "extension": [{"extension": [{"url": "type", "valueCode": "part-of"}, {"url": "targetReference", "valueReference": {"type": "Composition", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-conversion-report", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relates-to"}], "description": "This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide."}